Renal protective effects of Alpinate Oxyphyllae Fructus and mesenchymal stem cells co-treatment against D- galactose induced renal deterioration

• Published in: International journal of medical sciences 2024, Vol.21 (8), p.1491-1499
• Main Authors: Ho, Tsung-Jung, Shanmugam, Tamilselvi, Liao, Po-Hsiang, Shibu, Marthandam Asokan, Chen, William Shao-Tsu, Lin, Kuan-Ho, Lu, Shang-Yeh, Kuo, Chia-Hua, Kuo, Wei-Wen, Huang, Chih-Yang
• Format: Article
• Language: English
• Subjects: Animals; Apoptosis - drug effects; Drugs, Chinese Herbal - pharmacology; Drugs, Chinese Herbal - therapeutic use; Galactose - adverse effects; Humans; Kidney - drug effects; Kidney - pathology; Male; Mesenchymal Stem Cell Transplantation - methods; Mesenchymal Stem Cells - drug effects; Mesenchymal Stem Cells - metabolism; Oxidative Stress - drug effects; Rats; Renal Insufficiency, Chronic - chemically induced; Renal Insufficiency, Chronic - drug therapy; Renal Insufficiency, Chronic - pathology; Renal Insufficiency, Chronic - therapy; Research Paper
• ISSN: 1449-1907; 1449-1907
• DOI: 10.7150/ijms.96007

Age-related structural and functional changes in the kidney can eventually lead to development of chronic kidney disease, which is one of the leading causes of mortality among elderly people. For effective management of age-related kidney complications, it is important to identify new therapeutic interventions with minimal side-effects. The present study was designed to evaluate the synergistic effect of a traditional Chinese herb, Alpinate Oxyphyllae Fructus (AOF), and adipose-derived mesenchymal stem cells (ADMSCs) in ameliorating D-galactose (D-gal)-induced renal aging phenotypes in WKY rats. The study findings showed that D-gal-induced alteration in the kidney morphology was partly recovered by the AOF and ADMSC co-treatment. Moreover, the AOF and ADMSC co-treatment reduced the expression of proinflammatory mediators (NFkB, IL-6, and Cox2) and increased the expression of redox regulators (Nrf2 and HO-1) in the kidney, which were otherwise augmented by the D-gal treatment. Regarding kidney cell death, the AOF and ADMSC co-treatment was found to abolish the proapoptotic effects of D-gal by downregulating Bax and Bad expressions and inhibiting caspase 3 activation. Taken together, the study findings indicate that the AOF and ADMSC co-treatment protect the kidney from D-gal-induced aging by reducing cellular inflammation and oxidative stress and inhibiting renal cell death. This study can open up a new path toward developing novel therapeutic interventions using both AOF and ADMSC to effectively manage age-related renal deterioration.